COVID-19 ARDS and ARDS Share Price Scenarios, page-181

The numbers are really impressive and if our therapie will be approved im positive we will have huge number od customers.

but

maybe is common sense consider the numbers will not be exact as high as entire statistic shows now

for two or three obvious reasons

a) slowly the world will discover drug to minimize the number of severe cases
b) the process now in the way where countries keep social distancing etc will control the total numbers not as high as they are now
c) for sure other companies will develop other drugs to share the market

but i agree is highly positive for MSB and we have 100% the momentum for us.

but all will depend of the trial in the way in USA.

cato